Home / Share Price Target / Neclife
Nectar Lifesciences Share Price Target 2024, 2025, 2026 to 2039 With Charts
Nectar Lifesciences Limited | |||
 | Symbol: NECLIFE | ||
| Price: ₹35.26 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Nectar Lifesciences Brief Company Overview
- 1.1: Nectar Lifesciences Limited: A Pharmaceutical Powerhouse
- 1.2: Nectar Lifesciences Financial Performance
- 1.2.1: Is Nectar Lifesciences A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Nectar Lifesciences Share Price Target For 2024
- 2.1.1: Nectar Lifesciences Share Price Target Table For 2024
- 2.1.2: Summary: Nectar Lifesciences Share Price Prediction For 2024
- 2.2: Nectar Lifesciences Share Price Target For 2025
- 2.2.1: Nectar Lifesciences Share Price Target Table For 2025
- 2.2.2: Summary: Nectar Lifesciences Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Nectar Lifesciences Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Nectar Lifesciences Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Nectar Lifesciences Past Performance
Nectar Lifesciences Brief Company Overview
Nectar Lifesciences Limited: A Pharmaceutical Powerhouse
Established in 1995 and headquartered in Chandigarh, India, Nectar Lifesciences Limited is a leading manufacturer and distributor of pharmaceutical products, making its mark both domestically and internationally.
The company boasts a diverse product portfolio that includes:
- Active Pharmaceutical Ingredients and Intermediates: Cefixime, cefuroxime axetil, cefotaxime sodium, ceftriaxone sodium, etc.
- Contract Manufacturing: Tablets, capsules, dry powder oral suspensions, granules, and injectables for cephalosporins.
- Menthol and Mint Derivatives: Essential oils and extracts.
- Empty Hard Gelatin Capsules: Essential components for pharmaceutical formulations.
Nectar Lifesciences is renowned for its commitment to quality and innovation, earning a reputation as a trusted partner in the pharmaceutical industry.
Advertisement
Nectar Lifesciences Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 837.39 Crore | Market valuation of Nectar Lifesciences's shares. |
| Revenue (TTM) | 1,649.3 Crore | Total revenue generated by Nectar Lifesciences over the past twelve months. |
| Net Income (TTM) | +6.14 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 6.78% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 0.37% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | -8.9% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) | +63.1% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio | 59.43 | Company's total debt divided by total shareholder equity. |
| Total Debt | 635.53 Crore | Sum of Nectar Lifesciences's current & long-term financial obligations. |
| Total Cash | 20.3 Crore | Total amount of liquid funds available to Nectar Lifesciences. |
| Beta | 1.02 | Beta is greater than 1 indicating that the Nectar Lifesciences's price is more volatile than the market. |
Is Nectar Lifesciences A Good Buy For Long Term?
No valid response content found
To predict the Nectar Lifesciences's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Nectar Lifesciences Share Price Target For 2024
The line chart displays the monthly closing prices of Nectar Lifesciences with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Nectar Lifesciences shares in 2024, see the table below.
Advertisement
Nectar Lifesciences Share Price Target Table For 2024
| Nectar Lifesciences's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 36.31 (+2.97%) | Price Action: 21 Oct 2024 Low |
| 2024 Target 2 | 35.95 (+1.95%) | Price Action: Feb 2022 High |
| 2024 Target 1 | 35.59 (+0.93%) | Fibonacci Extension Level 123.6% |
| Current Price | 35.26 | Nectar Lifesciences's 1 share price as of Thu 14 Nov 2024 |
| Stop Loss 1 | 35.10 (-0.46%) | Price Action: Jul 2016 Low |
| Stop Loss 2 | 34.74 (-1.48%) | Price Action: 22 Oct 2024 Low |
| Stop Loss 3 | 34.27 (-2.81%) | Technical Indicator: MA250 |
Summary: Nectar Lifesciences Share Price Prediction For 2024
In summary, Nectar Lifesciences has surged by ₹3.11, achieving a notable +9.67% increase from 1st January 2024 to 14 Nov 2024. Our analysis of Nectar Lifesciences for 2024 predicts an additional rise of 0.93% to 2.97% by the end of 2024 with three potential targets T1: 35.59, T2: 35.95, T3: 36.31. Stop Loss at SL1: 35.10, SL2: 34.74, SL3: 34.27.
Nectar Lifesciences has a 52-week high of ₹56.50, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹25.00, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Nectar Lifesciences.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Nectar Lifesciences Share Price Target For 2025
The line chart displays the monthly closing prices of Nectar Lifesciences with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Nectar Lifesciences shares in 2025, see the table below.
Advertisement
Nectar Lifesciences Share Price Target Table For 2025
| Nectar Lifesciences's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 52.09 (+47.73%) | Price Action: Chart |
| 2025 Target 2 | 51.12 (+44.98%) | Fibonacci Extension Level 123.6% |
| 2025 Target 1 | 50.15 (+42.22%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 35.26 | Nectar Lifesciences's 1 share price as of Thu 14 Nov 2024 |
| Stop Loss 1 | 31.85 (-9.68%) | Price Action: Jan 2015 Low |
| Stop Loss 2 | 31.50 (-10.67%) | Price Action: Feb 2010 Low |
| Stop Loss 3 | 31.04 (-11.97%) | Price Action: Jun 2024 Low |
Summary: Nectar Lifesciences Share Price Prediction For 2025
In summary, Nectar Lifesciences has surged by ₹3.11, achieving a notable +9.67% increase from 1st January 2024 to 14 Nov 2024. Our analysis of Nectar Lifesciences for 2025 predicts an additional rise of 42.22% to 47.73% by the end of 2025 with three potential targets T1: 50.15, T2: 51.12, T3: 52.09. Stop Loss at SL1: 31.85, SL2: 31.50, SL3: 31.04.
Nectar Lifesciences has a All-Time high of ₹60.90, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹25.00, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Nectar Lifesciences, we have created a specific page for that check here: Nectar Lifesciences Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Nectar Lifesciences Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Nectar Lifesciences share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 10.82% over the next 15 years.
For complete year by year Nectar Lifesciences long term share price target from 2024, 2025 to 2039 check the below table.
Nectar Lifesciences Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Nectar Lifesciences Target | YoY Change % |
|---|---|---|
| 2024 | ₹35.26 | [Current Price] |
| 2024 | ₹41.92 | 18.88% |
| 2025 | ₹51.37 | 22.54% |
| 2026 | ₹57.45 | 11.83% |
| 2027 | ₹68.06 | 18.48% |
| 2028 | ₹81.77 | 20.12% |
| 2029 | ₹90.07 | 10.15% |
| 2030 | ₹99.36 | 10.31% |
| 2031 | ₹102.67 | 3.33% |
| 2032 | ₹114.36 | 11.38% |
| 2033 | ₹130.72 | 14.3% |
| 2034 | ₹138.22 | 5.74% |
| 2035 | ₹147.35 | 6.59% |
| 2036 | ₹147.88 | 0.36% |
| 2037 | ₹160.65 | 8.62% |
| 2038 | ₹179.67 | 11.83% |
| 2039 | ₹176.58 | -1.72% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Nectar Lifesciences Past Performance
- In 2005, Nectar Lifesciences opening price was ₹23.8
- As of Thu 14 Nov 2024 the price stands at ₹35.26.
- This represents a Compound Annual Growth Rate (CAGR) of 1.98%.
- In 19 years, an investment of 10,000 would have become ₹14,815.12.
As we wrap up, we hope you like our study on Nectar Lifesciences share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- Nectar Lifesciences Share Price History
- Nectar Lifesciences Price Target Tomorrow
- Nectar Lifesciences Dividend History
- Nectar Lifesciences Split History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
